Risk stratification for 1-year mortality in acute heart failure

Swiss Medical Weekly

Volumn 141, Issue OCTOBER, 2011, Pages

  Arenja, Nisha ^a   Breidthardt, Tobias ^a   Socrates, Thenral ^a   Schindler, Christian ^b   Heinisch, Corinna ^a   Tschung, Christopher ^a   Potocki, Mihael ^a   Gualandro, Danielle ^c   Mueller, Christian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

1 Year mortality; Acute heart failure; Risk stratification

Indexed keywords

ACUTE HEART FAILURE; AGE; AGED; ARTICLE; CLASSIFICATION; CLASSIFICATION AND REGRESSION TREE; CONFIDENCE INTERVAL; DEMOGRAPHY; FEMALE; FOLLOW UP; HAZARD RATIO; HIGH RISK POPULATION; HUMAN; KAPLAN MEIER METHOD; LABORATORY DIAGNOSIS; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UREA NITROGEN BLOOD LEVEL; VALIDATION PROCESS; ACUTE DISEASE; HEART FAILURE; METHODOLOGY; STATISTICS; SWITZERLAND;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK ASSESSMENT; SWITZERLAND;

EID: 80655147902     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: 10.4414/smw.2011.13259     Document Type: Article

References (39)

1. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388-442.
2. Nieminen MS, Böhm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:384-416. (Pubitemid 40283098)
3. Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP, et al. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004;292:344-50. (Pubitemid 38944258)
4. Selker HP,Griffith JL, D'Agostino RB. A time-insensitive predictive instrument for acute hospital mortality due to congestive heart failure: development, testing, and use for comparing hospitals: a multicenter study. Med Care. 1994;32:1040-52.
5. Chin MH,Goldman L. Correlates of major complications or death in patients admitted to the hospital with congestive heart failure. Arch Intern Med. 1996;156:1814-20. (Pubitemid 26295226)
6. Kearney MT, Fox KA, Lee AJ, Prescott RJ, Shah AM, Batin PD, et al. Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. J Am Coll Cardiol. 2002;40:1801-8. (Pubitemid 35341959)
7. Cohn JN, Johnson GR, Shabetai R, Loeb H, Tristani F, Rector T, et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation. 1993;87:VI5-16.
8. Salem R, Sibellas F, Socrates T, Arenja N, Yilmaz MB, Mueller C, et al. Novelties in the early management of acute heart failure syndromes. Swiss Med Wkly. 2010;140:w13031
9. Felker GM, Adams KF Jr, Konstam MA, O'Connor CM, Gheorghiade M. The problem of decompensated heart failure: nomenclature, classification, and risk stratification. Am Heart J. 2003;145:18-25.
10. Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293:572-80. (Pubitemid 40171239)
11. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003;290:2581-7. (Pubitemid 37443288)
12. Felker GM, Leimberger JD, Califf RM, Cuffe MS, Massie BM, Adams KF, Jr., et al. Risk stratification after hospitalization for decompensated heart failure. J Card Fail. 2004;10:460-6.
13. Zannad F, Mebazaa A, Juilliere Y, Cohen-Solal A, Guize L, Alla F, et al. Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study. Eur J Heart Fail. 2006;8:697-705. (Pubitemid 44754746)
14. Rudiger A, Harjola VP, Müller A, Mattila E, Saila P, Nieminen M, et al. Acute heart failure: clinical presentation, one-year mortality and prognostic factors. Eur J Heart Fail. 2005;7:662-70. (Pubitemid 40733001)
15. Maisel A, Mueller C, Adams K, Jr., Anker SD, Aspromonte N, Cleland JG, et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail. 2008;10:824-39.
16. Muller R, Möckel M. Logistic regression and CART in the analysis of multimarker studies. Clin Chim Acta. 2008;394:1-6.
17. Colombet I, Ruelland A, Chatellier G, Gueyffier F, Degoulet P, Jaulent MC. Models to predict cardiovascular risk: comparison of CART, multilayer perceptron and logistic regression. Proc AMIA Symp. 2000;156-60.
18. Fonarow GC. Epidemiology and risk stratification in acute heart failure. Am Heart J. 2008;155:200-7.
19. Noveanu M, Breidthardt T, Cayir S, Potocki M, Laule K, Mueller C. B-type natriuretic peptide-guided management and outcome in patients with obesity and dyspnea - results from the BASEL study. Am Heart J. 2009;158:488-95.
20. Boldanova T, Noveanu M, Breidthardt T, Potocki M, Reichlin T, Taegtmeyer A, et al. Impact of history of heart failure on diagnostic and prognostic value of BNP: results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) study. Int J Cardiol. 2010;142:265-72.
21. Christ M, Laule-Kilian K, Hochholzer W, Klima T, Breidthardt T, Perruchoud AP, et al. Gender-specific risk stratification with B-type natriuretic peptide levels in patients with acute dyspnea: insights from the B-type natriuretic peptide for acute shortness of breath evaluation study. J Am Coll Cardiol. 2006;48:1808-12. (Pubitemid 44648609)
22. Jong P, Vowinckel E, Liu PP, Gong Y, Tu JV. Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Arch Intern Med. 2002;162:1689-94.
23. Rohde LE, Goldraich L, Polanczyk CA, Borges AP, Biolo A, Rabelo E, et al. A simple clinically based predictive rule for heart failure in-hospital mortality. J Card Fail. 2006;12:587-93. (Pubitemid 44540258)
24. Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol. 2003;41:47-55. (Pubitemid 36044403)
25. Al Suwaidi J, Reddan DN, Williams K, Pieper KS, Harrington RA, Califf RM, et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation. 2002;106:974-80. (Pubitemid 34925333)
26. Aronson D, Mittleman MA, Burger AJ. Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. Am J Med. 2004;116:466-73. (Pubitemid 38388616)
27. Kazory A. Emergence of blood urea nitrogen as a biomarker of neurohormonal activation in heart failure. Am J Cardiol. 2010;106:694-700.
28. Filippatos G, Rossi J, Lloyd-Jones DM, Stough WG, Ouyang J, Shin DD, et al. Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study. J Card Fail. 2007;13:360-4. (Pubitemid 46977793)
29. Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, et al. Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF). Am J Cardiol. 2009;104:107-15.
30. Smith GL, Shlipak MG, Havranek EP, Foody JM, Masoudi FA, Rathore SS, et al. Serum urea nitrogen, creatinine, and estimators of renal function: mortality in older patients with cardiovascular disease. Arch Intern Med. 2006;166:1134-42. (Pubitemid 43765186)
31. Hauptman PJ, Goodlin SJ, Lopatin M, Costanzo MR, Fonarow GC, Yancy CW. Characteristics of patients hospitalized with acute decompensated heart failure who are referred for hospice care. Arch Intern Med. 2007;167:1990-7. (Pubitemid 47606640)
32. Krumholz HM, Wang Y, Parent EM, Mockalis J, Petrillo M, Radford MJ. Quality of care for elderly patients hospitalized with heart failure. Arch Intern Med. 1997;157:2242-7. (Pubitemid 27451150)
33. Cowburn PJ, Cleland JG, Coats AJ, Komajda M. Risk stratification in chronic heart failure. Eur Heart J. 1998;19:696-710. (Pubitemid 28227152)
34. Stewart S, Demers C, Murdoch DR, McIntyre K, MacLeod ME, Kendrick S, et al. Substantial between-hospital variation in outcome following first emergency admission for heart failure. Eur Heart J. 2002;23:650-7. (Pubitemid 35204250)
35. Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA, et al. Acute heart failure syndromes: current state and framework for future research. Circulation. 2005;112:3958-68. (Pubitemid 43739494)
36. Alla F, Zannad F, Filippatos G. Epidemiology of acute heart failure syndromes. Heart Fail Rev. 2007;12:91-5. (Pubitemid 46916953)
37. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, et al. The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003;24:442-63. (Pubitemid 36286187)
38. Tavazzi L, Maggioni AP, Lucci D, Cacciatore G, Ansalone G, Oliva F, et al. Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J. 2006;27:1207-15.
39. Pratt CM, Greenway PS, Schoenfeld MH, Hibben ML, Reiffel JA. Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials. Circulation. 1996;93:519-24. (Pubitemid 26043611)